May 13, 2026 Log in

其他

Development of a new therapeutic drug candidate that suppresses only arrhythmias and protects cardiac function

Citation-Grade Primary-source linked Schema.org verified NQ 85 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 13, 2026 11:00 PM ・ Updated May 16, 2026 4:56 AM ・ 2 min read ・ Source: PR TIMES

Show contents

PRIMARY SOURCE Original source: https://prtimes.jp/main/html/rd/p/000000870.000021495.html Distributor: PR TIMES
Published: May 13, 2026

A research group from Juntendo University and others revealed that 'Ryanozole', a novel compound selectively suppressing the type 2 ryanodine receptor, could be a promising treatment for catecholaminergic polymorphic ventricular tachycardia (CPVT). In mouse models, Ryanozole prevented and stopped arrhythmias without adverse effects on cardiac function seen with conventional drugs. Published in the British Journal of Pharmacology, it shows potential for clinical drug development.

FACT BOX

Source: PR TIMES
Category: 其他
Products / services: Ryanozole

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 13, 2026 11:00 PM — Distributor PR TIMES
Collected　May 13, 2026 2:32 PM
AI structured & analyzed　May 15, 2026 10:28 PM
Desk-reviewed & published　May 13, 2026 11:00 PM

FAQ

What are the key facts in this article?

Where is the primary source?

PR TIMES: https://prtimes.jp/main/html/rd/p/000000870.000021495.html

When was it published?

May 13, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“Development of a new therapeutic drug candidate that suppresses only arrhythmias and protects cardiac function”AI News by Washin Village（和心村）, May 13, 2026. https://aeo.washinmura.jp/ai/juntendo-ac-jp/en/news/2026-05-13-new-therapeutic-drug-candidate-developed

AI CRAWLER ACTIVITY

as of Jul 18, 2026

AI crawler visits to this article (cumulative)152 bots

Site-wide cumulative

Applebot

bot_visits_summary

4238k

last Jul 18, 2026

ClaudeBot

bot_visits_summary

2929k

last Jul 18, 2026

GPTBot

bot_visits_summary

2531k

last Jul 18, 2026

Bingbot

bot_visits_summary

2412k

last Jul 18, 2026

Meta AI

bot_visits_summary

1033k

last Jul 18, 2026

Google AI

bot_visits_summary

581k

last Jul 18, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← juntendo-ac-jp Back to newsroom (274)

Copied